TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 49 filers reported holding TYRA BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,344,143 | -18.6% | 896,452 | +0.6% | 0.00% | – |
| Q2 2023 | $15,170,869 | +41.6% | 890,832 | +33.6% | 0.00% | – |
| Q1 2023 | $10,716,843 | +115.3% | 666,885 | +1.8% | 0.00% | – |
| Q4 2022 | $4,978,692 | -8.9% | 655,091 | +5.3% | 0.00% | – |
| Q3 2022 | $5,468,000 | +21.2% | 622,098 | -1.4% | 0.00% | – |
| Q2 2022 | $4,510,000 | -27.7% | 630,855 | +8.2% | 0.00% | – |
| Q1 2022 | $6,242,000 | -24.6% | 583,236 | -0.9% | 0.00% | – |
| Q4 2021 | $8,281,000 | – | 588,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $31,531,000 | 11.23% |
| Nextech Invest Ltd. | 2,518,582 | $18,008,000 | 6.07% |
| Boxer Capital, LLC | 6,448,359 | $46,106,000 | 2.92% |
| TCG Crossover Management, LLC | 896,418 | $6,409,000 | 2.72% |
| Fairmount Funds Management LLC | 1,416,998 | $10,132,000 | 2.32% |
| RA Capital Management | 7,236,454 | $51,741,000 | 1.38% |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9,832,000 | 0.93% |
| BVF INC/IL | 2,472,327 | $17,677,000 | 0.85% |
| Sio Capital Management, LLC | 152,159 | $1,088,000 | 0.41% |
| Cormorant Asset Management, LP | 743,988 | $5,320,000 | 0.40% |